环庚三烯酮
|
T355510-250mg
|
≥96% |
539-80-0 |
250mg
|
¥ 138.9
|
现货 |
阿拉丁 |
2-十三碳烯酸
|
T352366-1g
|
≥95% |
6969-16-0 |
1g
|
¥ 124.9
|
现货 |
阿拉丁 |
2-十三碳烯酸
|
T352366-100g
|
≥95% |
6969-16-0 |
100g
|
¥ 4428.9
|
现货 |
阿拉丁 |
甲状腺素-4-羟基-3,5-二碘苯醚
|
T350596-5mg
|
≥95% |
911661-90-0 |
5mg
|
¥ 1647.9
|
现货 |
阿拉丁 |
四氯钴(II)酸四乙基铵
|
T349484-1g
|
≥98% |
6667-75-0 |
1g
|
¥ 925.9
|
现货 |
阿拉丁 |
反式-4-乙氧基苯基-4-丁基环己烷羧酸酯
|
T347332-5g
|
≥98% |
67589-47-3 |
5g
|
¥ 70.9
|
现货 |
阿拉丁 |
反式-4-乙氧基苯基-4-丁基环己烷羧酸酯
|
T347332-25g
|
≥98% |
67589-47-3 |
25g
|
¥ 269.9
|
现货 |
阿拉丁 |
反式-4-乙氧基苯基-4-丁基环己烷羧酸酯
|
T347332-1g
|
≥98% |
67589-47-3 |
1g
|
¥ 36.9
|
现货 |
阿拉丁 |
反式-4-乙氧基苯基-4-丁基环己烷羧酸酯
|
T347332-100g
|
≥98% |
67589-47-3 |
100g
|
¥ 838.9
|
现货 |
阿拉丁 |
4-(反-4-戊基环己基)苯基(反,反)-4'-丙基-[1,1'-双(环己烷)]-4-羧酸酯
|
T347053-5g
|
≥98% |
131790-57-3 |
5g
|
¥ 1434.9
|
现货 |
阿拉丁 |
4-(反-4-戊基环己基)苯基(反,反)-4'-丙基-[1,1'-双(环己烷)]-4-羧酸酯
|
T347053-1g
|
≥98% |
131790-57-3 |
1g
|
¥ 367.9
|
现货 |
阿拉丁 |
反式,反式-4'-(4'-戊基双环己基-4-基)-3,4-二氟联苯
|
T347048-5g
|
≥99% |
136609-96-6 |
5g
|
¥ 866.9
|
现货 |
阿拉丁 |
反式,反式-4'-(4'-戊基双环己基-4-基)-3,4-二氟联苯
|
T347048-25g
|
≥99% |
136609-96-6 |
25g
|
¥ 3423.9
|
现货 |
阿拉丁 |
反式-2-己烯醇苯乙酸酯
|
T345417-5ml
|
≥95% |
68133-78-8 |
5ml
|
¥ 137.9
|
现货 |
阿拉丁 |
反式-2-己烯醇苯乙酸酯
|
T345417-100ml
|
≥95% |
68133-78-8 |
100ml
|
¥ 2399.9
|
现货 |
阿拉丁 |
四苄基秋兰姆二硫化物
|
T345384-5g
|
≥97% |
10591-85-2 |
5g
|
¥ 69.9
|
现货 |
阿拉丁 |
四苄基秋兰姆二硫化物
|
T345384-25g
|
≥97% |
10591-85-2 |
25g
|
¥ 227.9
|
现货 |
阿拉丁 |
曲普立啶
|
T345207-25mg
|
Moligand™, ≥98%, mixture of cis and trans isomers |
486-12-4 |
25mg
|
¥ 2698.9
|
现货 |
阿拉丁 |
叔丁基二苯基膦
|
T344407-5g
|
≥96% |
6002-34-2 |
5g
|
¥ 139.9
|
现货 |
阿拉丁 |
叔丁基二苯基膦
|
T344407-25g
|
≥96% |
6002-34-2 |
25g
|
¥ 697.9
|
现货 |
阿拉丁 |
4-(反式-4-丙基环己基)-1-甲氧基-苯
|
T344118-5g
|
≥98% |
81936-32-5 |
5g
|
¥ 82.9
|
现货 |
阿拉丁 |
4-(反式-4-丙基环己基)-1-甲氧基-苯
|
T344118-25g
|
≥98% |
81936-32-5 |
25g
|
¥ 210.9
|
现货 |
阿拉丁 |
4'-(反式-4-戊基环己基)-3,4,5-三氟联苯
|
T343682-5g
|
≥98% |
137019-95-5 |
5g
|
¥ 132.9
|
现货 |
阿拉丁 |
4'-(反式-4-戊基环己基)-3,4,5-三氟联苯
|
T343682-25g
|
≥98% |
137019-95-5 |
25g
|
¥ 383.9
|
现货 |
阿拉丁 |